Yangxue Jiedu Fang Ameliorates Psoriasis by Regulating Vascular Regression via Survivin/PI3K/Akt Pathway

Hongpeng Lv,Xin Liu,Weiwen Chen,Shiju Xiao,Yunrun Ji,Xuyang Han,Yafan Li,Xiaoxu Wang,Guangzhong Zhang,Ping Li
DOI: https://doi.org/10.1155/2021/4678087
IF: 4.4929
2021-01-16
Journal of Immunology Research
Abstract:Background. Psoriasis (PA) is a chronic autoimmune disease of the skin that adversely affects patients’ quality of life. Yangxue Jiedu Fang (YXJD) has been used for decades to treat psoriasis in China. However, its antipsoriatic mechanisms are still poorly understood. In this study, we explored the effects of YXJD on angiogenesis and apoptosis of microvessels in PA, the underlying mechanisms in HUVEC cells transfected by Survivin overexpression plasmid and in a mouse model of imiquimod-induced psoriasis and the relationship between VEGF (vascular endothelial growth factor) and Survivin. Methods. A BALB/c mouse model of imiquimod- (IMQ-) induced PA was established, and the mice were treated with YXJD. Cell viability was assessed by CCK8 assay. Apoptosis was detected by annexin V–FITC/PI double-staining and caspase-3 assays. The PI3K/Akt/β-catenin pathway was analyzed by western blotting, ELISA, and immunochemical analysis. Results. YXJD ameliorated symptoms and psoriasis area and severity index (PASI) scores and also reduced the number of microvessels, as determined by the microvessel density (MVD). The expression of apoptotic protein Survivin in endothelial cells, autophagy-related proteins p62, and angiogenic proteins VEGF was inhibited by YXJD, and the repressed expression of LC3II/I increased by YXJD. The proteins related to the PI3K/Akt pathway and β-catenin expression and the nuclear entry of β-catenin were reduced in IMQ-induced PA mice treated with YXJD. In HUVEC cells transfected by Survivin overexpression plasmid, we observed YXJD regulated the expression of Survivin, LC3II/I, and p62, VEGF, and PI3K/Akt pathway-relative proteins and the nuclear entry of β-catenin. Conclusions. YXJD inhibited the expression of Survivin via PI3K/Akt pathway to adjust apoptosis, autophagy, and angiogenesis of microvessels and thus improve the vascular sustainability in psoriasis. YXJD may represent a new direction of drug research and development for immunomodulatory therapy for psoriasis.
immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the treatment mechanism of psoriasis (Psoriasis, PA), especially exploring the mechanism of action of the traditional Chinese medicine formula Yangxue Jiedu Fang (YXJD) in improving psoriasis by regulating vascular regression. Specifically, the study focuses on how YXJD adjusts the apoptosis, autophagy and angiogenesis of microvessels by inhibiting the Survivin/PI3K/Akt signaling pathway, thereby enhancing the vascular sustainability in psoriasis. This research aims to provide a new direction for drug development in the immunomodulatory treatment of psoriasis. ### Research Background - **Psoriasis**: A chronic autoimmune skin disease that seriously affects the quality of life of patients. - **Yangxue Jiedu Fang (YXJD)**: It has been used to treat psoriasis in China for decades, but its specific anti - psoriasis mechanism is still unclear. ### Research Objectives - To explore the effects of YXJD on the apoptosis, autophagy and angiogenesis of microvessels in psoriasis and its potential mechanisms. - To study the role of YXJD in human umbilical vein endothelial cells (HUVEC) with Survivin over - expression and in the imiquimod (IMQ) - induced psoriasis mouse model. - To analyze the influence of YXJD on the Survivin/PI3K/Akt signaling pathway. ### Main Findings - **Symptom Improvement**: YXJD significantly reduced the psoriasis area and severity index (PASI) and microvessel density (MVD). - **Survivin Expression Inhibition**: YXJD inhibited the expression of Survivin in endothelial cells. Survivin is a potent apoptosis - inhibiting protein. - **PI3K/Akt Pathway Regulation**: YXJD reduced the nuclear entry of β - catenin by inhibiting the expression of proteins related to the PI3K/Akt pathway, thus affecting cell activities. - **VEGF Level Reduction**: YXJD decreased the expression of vascular endothelial growth factor (VEGF), which is a key factor in promoting angiogenesis. - **Autophagy Regulation**: YXJD improved the autophagy - inhibiting phenomenon in psoriasis by increasing the LC3II/I ratio and reducing the expression of p62 protein. ### Conclusions - YXJD improves the vascular sustainability in psoriasis by inhibiting the Survivin/PI3K/Akt signaling pathway and regulating the apoptosis, autophagy and angiogenesis of microvessels. - YXJD may become a new direction for the immunomodulatory treatment of psoriasis and has important clinical application prospects.